These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 8480793

  • 21. Generic omeprazole delayed-release capsules: in vitro performance evaluations.
    Moore T, Smith A, Ye W, Toler DY, Westenberger BJ, Lionberger R, Raw A, Yu L, Buhse LF.
    Drug Dev Ind Pharm; 2009 Aug; 35(8):917-21. PubMed ID: 19555236
    [Abstract] [Full Text] [Related]

  • 22. Generic drugs: an overview.
    Helgeland D.
    S D Med; 2006 Apr; 59(4):161-3. PubMed ID: 16681165
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Switch-backs associated with generic drugs approved using product-specific determinations of therapeutic equivalence.
    Gagne JJ, Polinski JM, Jiang W, Dutcher SK, Xie J, Lii J, Fulchino LA, Kesselheim AS.
    Pharmacoepidemiol Drug Saf; 2016 Aug; 25(8):944-52. PubMed ID: 27102378
    [Abstract] [Full Text] [Related]

  • 29. Generic vs. brand name drugs--quality, not cost, is key issue.
    Stetler CJ.
    Internist; 1979 May; 20(4):9-10, 12. PubMed ID: 10242133
    [No Abstract] [Full Text] [Related]

  • 30. Critical therapeutic categories: a contraindication to generic substitution?
    Colaizzi JL, Lowenthal DT.
    Clin Ther; 1986 May; 8(4):370-9. PubMed ID: 3731208
    [Abstract] [Full Text] [Related]

  • 31. FDA mulls changes to bioequivalence standards.
    Traynor K.
    Am J Health Syst Pharm; 2010 Jun 01; 67(11):864. PubMed ID: 20484205
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. What's in a name? Generic vs brand name drugs.
    Levin AA.
    Health PAC Bull; 1986 Jun 01; 16(5):37, 39. PubMed ID: 10276741
    [No Abstract] [Full Text] [Related]

  • 36. Status of generic substitution: problematic drug classes reviewed.
    Ross MB.
    Hosp Formul; 1989 Aug 01; 24(8):441-4, 447-9. PubMed ID: 10294356
    [Abstract] [Full Text] [Related]

  • 37. Assessing the safety and comparative effectiveness of follow-on biologics (biosimilars) in the United States.
    Hennessy S, Leonard CE, Platt R.
    Clin Pharmacol Ther; 2010 Feb 01; 87(2):157-9. PubMed ID: 20107450
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration.
    Davit BM, Nwakama PE, Buehler GJ, Conner DP, Haidar SH, Patel DT, Yang Y, Yu LX, Woodcock J.
    Ann Pharmacother; 2009 Oct 01; 43(10):1583-97. PubMed ID: 19776300
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.